| Estradiol | IC50 | 0.01 [1], 0.7 [2], 1.5 [3] |
| Estradiol | Ki | 0.11 [1], 0.12 [2], 0.14 [3], 0.18 [4], 0.38 [5] |
| Tamoxifen | IC50 | 580.0 [1] |
| Tamoxifen | Ki | 11.9 [1], 34.4 [2], 157.0 [3] |
| Raloxifene | IC50 | 0.34 [1] |
| Acolbifene | IC50 | 0.14 [1], 0.55 [2] |
| Acolbifene | Ki | 0.04 [1], 0.05 [2], 0.07 [3], 0.08 [4] |
| Fulvestrant | IC50 | 0.21 [1], 4.0 [2], 5.0 [3] |
| Fulvestrant | Ki | 0.67 [1], 0.76 [2], 7.63 [3] |
| Afimoxifene | IC50 | 0.5 [1], 2.6 [2], 3.0 [3], 7.0 [4] |
| Afimoxifene | Ki | 0.25 [1], 0.35 [2] |
| Unii-xcr716lecp | IC50 | 0.14 [1], 1.3 [2] |
| Unii-xcr716lecp | Ki | 0.02 [1], 4.71 [2], 11.14 [3] |
| Progesterone | IC50 | 1000.0 [1], 10000.0 [2] |
| Progesterone | Ki | 10000.0 [1] |
| Mifepristone | IC50 | 1000.0 [1], 2244.0 [2], 10000.0 [3] |
| Mifepristone | Ki | 10000.0 [1] |
| (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)-phenyl)-2-phenylbut-1-en-1-yl)phenol | IC50 | 1.58 [1], 2.6 [2], 10.0 [3], 510.0 [4] |
| N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide | Ki | 1.53 [1], 1.76 [2], 2.33 [3], 4.6 [4] |
| (2S,3R)-3-(4-Hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | IC50 | 2.8 [1], 3.0 [2], 9.6 [3] |
| (2R)-3-(4-Hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-7-ol | IC50 | 8.4 [1], 15.0 [2] |
| (2R)-3-(4-Hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-7-ol | Ki | 1.89 [1], 2.09 [2] |
| Onapristone | IC50 | 1000.0 [1] |
| Onapristone | Ki | 20.0 [1] |
| [4-[(2R)-7-(2,2-Dimethylpropanoyloxy)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-3-yl]phenyl] 2,2-dimethylpropanoate | IC50 | 36.2 [1] |
| [4-[(2R)-7-(2,2-Dimethylpropanoyloxy)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-3-yl]phenyl] 2,2-dimethylpropanoate | Ki | 4.22 [1], 270.0 [2] |
| 2-(4-Hydroxyphenyl)-3-methyl-1-(10-pentylsulfonyldecyl)-5-indolol | IC50 | 1.4 [1], 20.0 [2], 50.0 [3] |
| 4-[(E)-4-(4-Hydroxyphenyl)-10-[methyl-[3-(4,4,5,5,5-pentafluoropentylsulfanyl)propyl]amino]dec-3-en-3-yl]phenol | IC50 | 0.22 [1], 7.0 [2], 10.0 [3] |
| 3-[(E)-3-(4-Hydroxyphenyl)-14-pentylsulfonyltetradec-3-en-4-yl]phenol | IC50 | 49.0 [1], 270.0 [2], 370.0 [3] |
| 4-[(E)-4-(4-Hydroxyphenyl)-14-pentylsulfonyltetradec-3-en-3-yl]phenol | IC50 | 5.1 [1], 100.0 [2], 130.0 [3] |
| 3-[(E)-4-(4-Hydroxyphenyl)-14-pentylsulfonyltetradec-3-en-3-yl]phenol | IC50 | 6.1 [1], 50.0 [2], 110.0 [3] |
| 4-[(E)-4-(4-Hydroxyphenyl)-10-[methyl(3-pentylsulfanylpropyl)amino]dec-3-en-3-yl]phenol | IC50 | 0.75 [1], 10.0 [2] |
| Diethylstilbestrol | Ki | 0.13 [1] |
| Medroxyprogesterone acetate | IC50 | 924.0 [1] |
| Raloxifene hydrochloride | IC50 | 0.37 [1], 4.32 [2] |
| Lasofoxifene | IC50 | 0.1 [1], 2.3 [2] |
| E-Guggulsterone | IC50 | 5000.0 [1] |
| E-Guggulsterone | Ki | 5000.0 [1] |
| Guggulsterone | IC50 | 5000.0 [1] |
| Guggulsterone | Ki | 5000.0 [1] |
| Moxestrol | IC50 | 2.5 [1], 2.9 [2] |
| Unii-IS4M82C29X | IC50 | 9.5 [1] |
| [(5R)-2-(2,2-Dimethylpropanoyloxy)-5-[4-(2-piperidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromen-8-yl] 2,2-dimethylpropanoate | IC50 | 175.0 [1], 510.0 [2] |
| Rac-Acolbifene | IC50 | 0.24 [1] |
| Rac-Acolbifene | Ki | 0.03 [1] |
| 2-[4-(2-Piperidinoethoxy)phenyl]-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol | IC50 | 4.6 [1] |
| 2-[4-(2-Piperidinoethoxy)phenyl]-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol | Ki | 0.53 [1] |
| (R)-5-Bromo-2-((2,2-dimethyl-6-methylenecyclohexyl)methyl)-4-methoxyphenol | IC50 | 10000.0 [1] |
| (R)-5-Bromo-2-((2,2-dimethyl-6-methylenecyclohexyl)methyl)-4-methoxyphenol | Ki | 10000.0 [1] |
| 5-[4-(2-Piperidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 12.0 [1], 110.0 [2] |
| (5S)-5-[4-(2-Piperidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 17.1 [1], 416.0 [2] |
| (5R)-5-[4-(2-Piperidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 43.3 [1], 599.0 [2] |
| [(5S)-2-(2,2-Dimethylpropanoyloxy)-5-[4-(2-piperidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromen-8-yl] 2,2-dimethylpropanoate | IC50 | 99.0 [1], 670.0 [2] |
| 12-[4-(2-Piperidin-1-ylethoxy)phenyl]-7,12-dihydrobenzo[a]anthracene-3,11-diol | IC50 | 68.0 [1], 580.0 [2] |
| [2-(4-Ethynylphenyl)-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | IC50 | 0.8 [1] |
| 1-Nitro-4-[(2-methylene-4,6,6-trimethyl-3-cyclohexenyl)methyl]benzene | IC50 | 10000.0 [1] |
| 1-Nitro-4-[(2-methylene-4,6,6-trimethyl-3-cyclohexenyl)methyl]benzene | Ki | 10000.0 [1] |
| 12-[4-(2-Piperidin-1-ylethoxy)phenyl]-7,12-dihydrobenzo[a]anthracene-3,10-diol | IC50 | 6.6 [1], 130.0 [2] |
| 12-[4-(2-Piperidin-1-ylethoxy)phenyl]-7,12-dihydrobenzo[a]anthracene-3,8-diol | IC50 | 2.9 [1], 50.0 [2] |
| 4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]benzoic acid | IC50 | 325.0 [1] |
| Ethyl 4-[6-hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]benzoate | IC50 | 50.0 [1] |
| 1-[4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenyl]ethanone | IC50 | 32.0 [1] |
| [2-(4-Diethoxyphosphorylphenyl)-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | IC50 | 210.0 [1] |
| 4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]benzamide | IC50 | 200.0 [1] |
| 4-[6-Hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]-N,N-dimethylbenzamide | IC50 | 20.0 [1] |
| 1-[2-(4-Hydroxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-6-yl]ethanone | IC50 | 60.0 [1] |
| Methyl 4-[6-hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]benzoate | IC50 | 50.0 [1] |
| 3-[(E)-4-(4-Hydroxyphenyl)-14-pentylsulfanyltetradec-3-en-3-yl]phenol | IC50 | 200.0 [1], 590.0 [2] |
| N,N-Dimethyl-2-[4-(4-phenyl-2,3-dihydro-1-benzoxepin-5-yl)phenoxy]ethanamine | IC50 | 16200.0 [1] |
| N,N-Dimethyl-2-[4-(4-phenyl-2,3-dihydro-1-benzoxepin-5-yl)phenoxy]ethanamine | Ki | 3200.0 [1] |
| N,N-Dimethyl-2-[4-[4-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-5-yl]phenoxy]ethanamine | IC50 | 15700.0 [1] |
| N,N-Dimethyl-2-[4-[4-(4-methylphenyl)-2,3-dihydro-1-benzoxepin-5-yl]phenoxy]ethanamine | Ki | 828000.0 [1] |
| 3-[(E)-3-(4-Hydroxyphenyl)-14-pentylsulfanyltetradec-3-en-4-yl]phenol | IC50 | 1200.0 [1], 2100.0 [2] |
| 4-[(E)-4-(4-Hydroxyphenyl)-14-pentylsulfanyltetradec-3-en-3-yl]phenol | IC50 | 790.0 [1], 1400.0 [2] |
| 5-[4-(2-Pyrrolidin-1-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 80.0 [1], 150.0 [2] |
| 5-[4-[2-(Dimethylamino)ethoxy]phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 180.0 [1], 220.0 [2] |
| 5-[4-(2-Morpholin-4-ylethoxy)phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 410.0 [1], 1400.0 [2] |
| 5-[4-[2-(Azepan-1-yl)ethoxy]phenyl]-5,11-dihydrochromeno[4,3-c]chromene-2,8-diol | IC50 | 13.0 [1], 660.0 [2] |
| 6-(4-Fluorophenyl)-5-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}naphthalen-2-ol | IC50 | 0.34 [1], 3.18 [2] |
| 2-(4-Hydroxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophene-6-carboxamide | IC50 | 30.0 [1], 1000.0 [2] |
| 11-[4-(1-Hydroxy-3-piperidin-1-ylpropyl)phenyl]-6,11-dihydronaphtho[2,3-b][1]benzothiole-3,9-diol | IC50 | 0.9 [1], 53.0 [2] |
| 11-[4-(1-Hydroxy-3-piperidin-1-ylpropyl)phenyl]-6,11-dihydronaphtho[6,7-b][1]benzothiole-3,10-diol | IC50 | 42.0 [1], 680.0 [2] |
| 11-[4-(1-Hydroxy-3-piperidin-1-ylpropyl)phenyl]-6,11-dihydronaphtho[2,3-b][1]benzothiol-3-ol | IC50 | 17.0 [1], 710.0 [2] |
| 11-[4-(1-Hydroxy-3-piperidin-1-ylpropyl)phenyl]-6,11-dihydronaphtho[3,2-b][1]benzothiole-3,8-diol | IC50 | 0.7 [1], 45.0 [2] |
| 12-[4-(2-Piperidin-1-ylethoxy)phenyl]benzo[a]anthracene-3,10-diol | IC50 | 57.0 [1], 820.0 [2] |
| 11-[4-(1-Hydroxy-3-piperidin-1-ylpropyl)phenyl]naphtho[2,3-b][1]benzothiole-3,9-diol | IC50 | 1.0 [1], 690.0 [2] |
| (E)-7,8-Bis(4-hydroxyphenyl)-N-methyl-N-[3-(4,4,5,5,5-pentafluoropentylsulfanyl)propyl]dec-7-enamide | IC50 | 310.0 [1], 700.0 [2] |
| (E)-7,8-Bis(4-hydroxyphenyl)-N-methyl-N-(3-pentylsulfanylpropyl)dec-7-enamide | IC50 | 600.0 [1], 19000.0 [2] |
| 12-[4-(2-Piperidin-1-ylethoxy)phenyl]-7,12-dihydrobenzo[a]anthracene-3,9-diol | IC50 | 1.9 [1], 31.0 [2] |
| [6-Ethynyl-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | IC50 | 20.0 [1] |
| [6-Diethoxyphosphoryl-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | IC50 | 200.0 [1] |
| 6-(4-Methanesulfonyl-phenyl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol Hydrochloride | IC50 | 0.86 [1], 10.7 [2] |
| 6-(4-Hydroxyphenyl)-5-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]naphthalen-2-ol;hydrochloride | IC50 | 0.2 [1], 1.14 [2] |
| [2-(4-Ethenylphenyl)-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | IC50 | 7.0 [1] |
| 6-(4-Methylsulfonylphenyl)-5-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]naphthalen-2-ol | IC50 | 3.4 [1], 4.78 [2] |
| Prednisolone | Ki | 1000.0 [1] |
| Genistein | IC50 | 990.0 [1] |
| Apigenin | IC50 | 14000.0 [1] |
| Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]- | IC50 | 7.0 [1] |
| Stallimycin | IC50 | 20.0 [1] |